Skip to content
Lower risk Medical device recall · FDA · Published July 14, 2022

Roche cobas e801 Immunoassay Analyzer recall: Software issue affects test results

Roche recalls cobas e801 Immunoassay Analyzers with software issue causing inaccurate Pre-Wash test results. Affected units have specific serial numbers and catalog numbers. Consumers should contact Roche for details.

🇺🇸 FDA recall #Z-1515-2022Medical deviceRoche ›
Take action

Contact the company

Recalling firmRoche Diagnostics Operations, Inc.9115 Hague Rd · Indianapolis, IN 46256-1025
✎ GovInfoNow plain-language explainer

Roche is recalling cobas e801 Immunoassay Analyzers due to a software issue that can cause inaccurate results for specific tests. This affects laboratory use and could lead to incorrect medical diagnoses if the device is used without correction. Read more at govinfonow.com/recall/60365-roche-cobas-e801-immunoassay-analyzer-recall-software-issue-affects-test.

Source Summary by GovInfoNow · govinfonow.com/recall/60365-roche-cobas-e801-immunoassay-analyzer-recall-software-issue-affects-test · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1515-2022

Cite this page

“Roche cobas e801 Immunoassay Analyzer recall: Software issue affects test results.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60365-roche-cobas-e801-immunoassay-analyzer-recall-software-issue-affects-test. Based on FDA recall #Z-1515-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1515-2022%22&limit=1).

The FDA announced on July 14, 2022, that Roche Diagnostics Operations, Inc. is recalling cobas e801 Immunoassay Analyzers due to a software issue impacting test results. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Roche
  • Product: cobas e801 Immunoassay Analyzer
  • UDI-DI: 07613336158456 and 04015630946198
  • Catalog No.: 08454345001 and 07682913001
  • All serial numbers
  • Units affected: 965

The hazard

A software issue results in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1, Myogloin, Rubella IgG, and Toxo IgG.

Context

GovInfoNow's records show Roche Diagnostics Operations, Inc. has 32 other recalls on record since July 2, 2019. Other recent recalls of similar products include Roche cobas pro integrated solutions recall (Jan. 20, 2026), Roche Elecsys Anti-TSHR Assay Recall (Nov. 21, 2025), and Roche cobas HCYS Assay Recall (Oct. 17, 2024). Other recent recalls of similar products include DASH Rapid PCR Instrument Software Issue Recall (Oct. 22, 2025), Siemens Atellica CH A1c_E Test Recall (June 8, 2026), and Beckman Coulter MicroScan LabPro V5.03 Panel Update 11 DVD Kit (June 26, 2026).

How to tell if you have this one

Check the serial numbers or catalog numbers listed in the recall notice: UDI-DI 07613336158456 and 04015630946198, or catalog numbers 08454345001 and 07682913001. All units with these identifiers are affected.

  • Brand
    Roche
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Contact Roche

    Reach out to Roche Diagnostics Operations, Inc. for specific guidance on the recall and next steps.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 45 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, DC &…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 34 days after the firm started it.

1. Firm started the recall: Jul 14, 202212. FDA classified it Class II: Aug 11, 202223. Published in FDA’s Enforcement Report: Aug 17, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1515-2022 (July 14, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1515-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA